US6585763B1
(en)
*
|
1997-10-14 |
2003-07-01 |
Vascusense, Inc. |
Implantable therapeutic device and method
|
US6775574B1
(en)
*
|
1997-11-07 |
2004-08-10 |
Medtronic, Inc. |
Method and system for myocardial infarction repair
|
AU733053C
(en)
|
1998-02-24 |
2001-11-29 |
Boston Scientific Limited |
High flow rate dialysis catheters and related methods
|
AU3973599A
(en)
|
1998-05-08 |
1999-11-29 |
Genetronics, Inc. |
Electrically induced vessel vasodilation
|
US6300108B1
(en)
|
1999-07-21 |
2001-10-09 |
The Regents Of The University Of California |
Controlled electroporation and mass transfer across cell membranes
|
US20060127466A1
(en)
*
|
2000-02-25 |
2006-06-15 |
Arindam Sen |
Method for transdermal or intradermal delivery of molecules
|
CA2401239A1
(en)
*
|
2000-03-03 |
2001-09-13 |
Valentis, Inc. |
Improved poloxamer and poloxamine compositions for nucleic acid delivery
|
US6892099B2
(en)
|
2001-02-08 |
2005-05-10 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits, virtual face lift and body sculpturing by electroporation
|
US6697670B2
(en)
|
2001-08-17 |
2004-02-24 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients
|
US6795728B2
(en)
|
2001-08-17 |
2004-09-21 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits by electroporation
|
US8251986B2
(en)
|
2000-08-17 |
2012-08-28 |
Angiodynamics, Inc. |
Method of destroying tissue cells by eletroporation
|
US6994706B2
(en)
|
2001-08-13 |
2006-02-07 |
Minnesota Medical Physics, Llc |
Apparatus and method for treatment of benign prostatic hyperplasia
|
USRE42016E1
(en)
|
2001-08-13 |
2010-12-28 |
Angiodynamics, Inc. |
Apparatus and method for the treatment of benign prostatic hyperplasia
|
AU2002348417B9
(en)
|
2001-10-26 |
2010-02-04 |
Baylor College Of Medicine |
A composition and method to alter lean body mass and bone properties in a subject
|
US6733518B2
(en)
*
|
2001-10-31 |
2004-05-11 |
Seacoast Technologies, Inc. |
Method and apparatus for thermal therapy
|
US7211083B2
(en)
*
|
2003-03-17 |
2007-05-01 |
Minnesota Medical Physics, Llc |
Apparatus and method for hair removal by electroporation
|
US7261882B2
(en)
|
2003-06-23 |
2007-08-28 |
Reagents Of The University Of Colorado |
Methods for treating neuropathic pain by administering IL-10 polypeptides
|
WO2005016964A2
(en)
|
2003-08-04 |
2005-02-24 |
Advisys, Inc. |
Canine specific growth hormone releasing hormone
|
ES2729378T3
(es)
|
2003-12-24 |
2019-11-04 |
Univ California |
Ablación de tejido con electroporación irreversible
|
US8298222B2
(en)
|
2003-12-24 |
2012-10-30 |
The Regents Of The University Of California |
Electroporation to deliver chemotherapeutics and enhance tumor regression
|
CA2592891C
(en)
|
2003-12-31 |
2013-05-28 |
Advisys, Inc. |
Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation
|
WO2005073371A2
(en)
|
2004-01-20 |
2005-08-11 |
Advisys, Inc. |
Enhanced secretion/retention of growth hormone releasing hormone (ghrh) from muscle cells by species-specific signal peptide
|
US7840263B2
(en)
|
2004-02-27 |
2010-11-23 |
Cardiac Pacemakers, Inc. |
Method and apparatus for device controlled gene expression
|
US7764995B2
(en)
|
2004-06-07 |
2010-07-27 |
Cardiac Pacemakers, Inc. |
Method and apparatus to modulate cellular regeneration post myocardial infarct
|
US7729761B2
(en)
|
2004-07-14 |
2010-06-01 |
Cardiac Pacemakers, Inc. |
Method and apparatus for controlled gene or protein delivery
|
SG123643A1
(en)
*
|
2004-12-28 |
2006-07-26 |
Nanyan Polytechnic |
Programmable apparatus and method for optimizing and real time monitoring of gene transfection basedon user configured arbitrary waveform pulsing tra in
|
US8524678B2
(en)
|
2005-05-31 |
2013-09-03 |
The Regents Of The University Of Colorado, A Body Corporate |
Method for delivering genes
|
US20060293730A1
(en)
|
2005-06-24 |
2006-12-28 |
Boris Rubinsky |
Methods and systems for treating restenosis sites using electroporation
|
US8114070B2
(en)
|
2005-06-24 |
2012-02-14 |
Angiodynamics, Inc. |
Methods and systems for treating BPH using electroporation
|
WO2007104755A1
(en)
|
2006-03-13 |
2007-09-20 |
Novo Nordisk A/S |
Secure pairing of electronic devices using dual means of communication
|
EP1997234A1
(de)
*
|
2006-03-13 |
2008-12-03 |
Novo Nordisk A/S |
Medizinisches system mit zweifach verwendbaren kommunikationsmitteln
|
WO2008006019A2
(en)
|
2006-07-06 |
2008-01-10 |
Advisys Inc. |
Growth hormone releasing hormone treatment to decrease cholesterol levels
|
WO2008048620A2
(en)
|
2006-10-16 |
2008-04-24 |
The Regents Of The University Of California |
Gels with predetermined conductivity used in irreversible electroporation of tissue
|
US20090248012A1
(en)
|
2008-03-27 |
2009-10-01 |
The Regents Of The University Of California |
Irreversible electroporation device and method for attenuating neointimal
|
US9598691B2
(en)
|
2008-04-29 |
2017-03-21 |
Virginia Tech Intellectual Properties, Inc. |
Irreversible electroporation to create tissue scaffolds
|
US10117707B2
(en)
|
2008-04-29 |
2018-11-06 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
|
US9867652B2
(en)
|
2008-04-29 |
2018-01-16 |
Virginia Tech Intellectual Properties, Inc. |
Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
|
US10238447B2
(en)
|
2008-04-29 |
2019-03-26 |
Virginia Tech Intellectual Properties, Inc. |
System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
|
US8992517B2
(en)
|
2008-04-29 |
2015-03-31 |
Virginia Tech Intellectual Properties Inc. |
Irreversible electroporation to treat aberrant cell masses
|
US10272178B2
(en)
|
2008-04-29 |
2019-04-30 |
Virginia Tech Intellectual Properties Inc. |
Methods for blood-brain barrier disruption using electrical energy
|
US11254926B2
(en)
|
2008-04-29 |
2022-02-22 |
Virginia Tech Intellectual Properties, Inc. |
Devices and methods for high frequency electroporation
|
US9198733B2
(en)
*
|
2008-04-29 |
2015-12-01 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning for electroporation-based therapies
|
US10448989B2
(en)
|
2009-04-09 |
2019-10-22 |
Virginia Tech Intellectual Properties, Inc. |
High-frequency electroporation for cancer therapy
|
US9283051B2
(en)
|
2008-04-29 |
2016-03-15 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating a treatment volume for administering electrical-energy based therapies
|
US10245098B2
(en)
|
2008-04-29 |
2019-04-02 |
Virginia Tech Intellectual Properties, Inc. |
Acute blood-brain barrier disruption using electrical energy based therapy
|
US10702326B2
(en)
|
2011-07-15 |
2020-07-07 |
Virginia Tech Intellectual Properties, Inc. |
Device and method for electroporation based treatment of stenosis of a tubular body part
|
US11272979B2
(en)
|
2008-04-29 |
2022-03-15 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
|
US20090281477A1
(en)
|
2008-05-09 |
2009-11-12 |
Angiodynamics, Inc. |
Electroporation device and method
|
US8849395B2
(en)
|
2008-05-30 |
2014-09-30 |
Boston Scientific Scimed, Inc. |
Guide catheter having vasomodulating electrodes
|
WO2009155526A2
(en)
|
2008-06-20 |
2009-12-23 |
Angiodynamics, Inc. |
Device and method for the ablation of fibrin sheath formation on a venous catheter
|
WO2010008834A2
(en)
|
2008-06-23 |
2010-01-21 |
Angiodynamics, Inc. |
Treatment devices and methods
|
WO2010085765A2
(en)
|
2009-01-23 |
2010-07-29 |
Moshe Meir H |
Therapeutic energy delivery device with rotational mechanism
|
US8231603B2
(en)
|
2009-02-10 |
2012-07-31 |
Angiodynamics, Inc. |
Irreversible electroporation and tissue regeneration
|
US20100249488A1
(en)
*
|
2009-03-30 |
2010-09-30 |
MagneGene, Inc. |
Method of contactless magnetic electroporation
|
US11638603B2
(en)
|
2009-04-09 |
2023-05-02 |
Virginia Tech Intellectual Properties, Inc. |
Selective modulation of intracellular effects of cells using pulsed electric fields
|
US11382681B2
(en)
|
2009-04-09 |
2022-07-12 |
Virginia Tech Intellectual Properties, Inc. |
Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
|
WO2010118387A1
(en)
|
2009-04-09 |
2010-10-14 |
Virginia Tech Intellectual Properties, Inc. |
Integration of very short electric pulses for minimally to noninvasive electroporation
|
USD630321S1
(en)
|
2009-05-08 |
2011-01-04 |
Angio Dynamics, Inc. |
Probe handle
|
WO2010137021A2
(en)
|
2009-05-27 |
2010-12-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
US8903488B2
(en)
|
2009-05-28 |
2014-12-02 |
Angiodynamics, Inc. |
System and method for synchronizing energy delivery to the cardiac rhythm
|
US9895189B2
(en)
|
2009-06-19 |
2018-02-20 |
Angiodynamics, Inc. |
Methods of sterilization and treating infection using irreversible electroporation
|
US20110118732A1
(en)
|
2009-11-19 |
2011-05-19 |
The Regents Of The University Of California |
Controlled irreversible electroporation
|
JP5785559B2
(ja)
|
2009-12-16 |
2015-09-30 |
クロンテック ファーマ アーベー |
注射針および注射装置
|
EP2600901B1
(de)
|
2010-08-06 |
2019-03-27 |
ModernaTX, Inc. |
Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung
|
CN104531671A
(zh)
|
2010-10-01 |
2015-04-22 |
现代治疗公司 |
设计核酸及其使用方法
|
US9700368B2
(en)
|
2010-10-13 |
2017-07-11 |
Angiodynamics, Inc. |
System and method for electrically ablating tissue of a patient
|
WO2012106281A2
(en)
|
2011-01-31 |
2012-08-09 |
The General Hospital Corporation |
Multimodal trail molecules and uses in cellular therapies
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
CA2839196A1
(en)
|
2011-06-15 |
2012-12-20 |
Chrontech Pharma Ab |
Injection needle and device
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
US9078665B2
(en)
|
2011-09-28 |
2015-07-14 |
Angiodynamics, Inc. |
Multiple treatment zone ablation probe
|
EP2763701B1
(de)
|
2011-10-03 |
2018-12-19 |
Moderna Therapeutics, Inc. |
Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
|
JP2015501844A
(ja)
|
2011-12-16 |
2015-01-19 |
モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. |
修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
|
DE102012000354A1
(de)
*
|
2012-01-11 |
2013-07-11 |
Udo Tartler |
Vorrichtung für eine Angussöffnung einer Gussform
|
US9414881B2
(en)
|
2012-02-08 |
2016-08-16 |
Angiodynamics, Inc. |
System and method for increasing a target zone for electrical ablation
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
DE18200782T1
(de)
|
2012-04-02 |
2021-10-21 |
Modernatx, Inc. |
Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
|
EP2890720B1
(de)
|
2012-08-30 |
2019-07-17 |
The General Hospital Corporation |
Zusammensetzungen und verfahren zur behandlung von krebs
|
WO2014064534A2
(en)
|
2012-10-05 |
2014-05-01 |
Chrontech Pharma Ab |
Injection needle, device, immunogenic compositions and method of use
|
HRP20220607T1
(hr)
|
2012-11-26 |
2022-06-24 |
Modernatx, Inc. |
Terminalno modificirana rna
|
US9888956B2
(en)
|
2013-01-22 |
2018-02-13 |
Angiodynamics, Inc. |
Integrated pump and generator device and method of use
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
ES2825078T3
(es)
|
2013-03-15 |
2021-05-14 |
Univ Loma Linda |
Tratamiento de enfermedades autoinmunitarias
|
EP3848044A1
(de)
|
2013-05-21 |
2021-07-14 |
President and Fellows of Harvard College |
Manipulierte heme-bindende zusammensetzungen und verwendungen davon
|
EA201690675A1
(ru)
|
2013-10-03 |
2016-08-31 |
Модерна Терапьютикс, Инк. |
Полинуклеотиды, кодирующие рецептор липопротеинов низкой плотности
|
US10166321B2
(en)
|
2014-01-09 |
2019-01-01 |
Angiodynamics, Inc. |
High-flow port and infusion needle systems
|
JP6594901B2
(ja)
|
2014-05-12 |
2019-10-23 |
バージニア テック インテレクチュアル プロパティース インコーポレイテッド |
パルス電界を使用した細胞の細胞内効果の選択的調節
|
WO2016100325A1
(en)
|
2014-12-15 |
2016-06-23 |
Virginia Tech Intellectual Properties, Inc. |
Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
|
US20180112006A1
(en)
|
2015-04-17 |
2018-04-26 |
The General Hospital Corporation |
Agents, systems and methods for treating cancer
|
US10660691B2
(en)
|
2015-10-07 |
2020-05-26 |
Angiodynamics, Inc. |
Multiple use subassembly with integrated fluid delivery system for use with single or dual-lumen peristaltic tubing
|
US10233419B2
(en)
|
2016-06-30 |
2019-03-19 |
Zymergen Inc. |
Apparatuses and methods for electroporation
|
WO2018089690A1
(en)
|
2016-11-09 |
2018-05-17 |
Sigma Genetics, Inc. |
Systems, devices, and methods for elecroporation induced by magnetic fields
|
US10905492B2
(en)
|
2016-11-17 |
2021-02-02 |
Angiodynamics, Inc. |
Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
|
US11607537B2
(en)
|
2017-12-05 |
2023-03-21 |
Virginia Tech Intellectual Properties, Inc. |
Method for treating neurological disorders, including tumors, with electroporation
|
US11925405B2
(en)
|
2018-03-13 |
2024-03-12 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning system for immunotherapy enhancement via non-thermal ablation
|
US11311329B2
(en)
|
2018-03-13 |
2022-04-26 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
|
EP4126028A1
(de)
|
2020-03-27 |
2023-02-08 |
Svenska Vaccinfabriken Produktion AB |
Zusammensetzungen und verfahren zur behandlung und prävention von coronaviren
|
WO2023056284A1
(en)
|
2021-09-29 |
2023-04-06 |
Svenska Vaccinfabriken Produktion Ab |
Compositions and methods for treating and preventing coronavirus infection
|